Retrospective data analyses of social and environmental determinants of malaria control for elimination prospects in Eritrea.


Journal

Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774

Informations de publication

Date de publication:
12 Mar 2020
Historique:
received: 23 01 2019
accepted: 17 02 2020
entrez: 14 3 2020
pubmed: 14 3 2020
medline: 21 10 2020
Statut: epublish

Résumé

The present study focuses on both long- and short-term malaria transmission in Eritrea and investigates the risk factors. Annual aggregates of information on malaria cases, deaths, diagnostics and control interventions from 2001 to 2008 and monthly reported data from 2009 to 2017 were obtained from the National Malaria Control Programme. We used a generalized linear regression model to examine the associations among total malaria cases, death, insecticide-treated net coverage, indoor residual spraying and climatic parameters. Reduction in malaria mortality is demonstrated by the milestone margins of over 97% by the end of 2017. Malaria incidence likewise declined during the period (from 33 to 5 per 1000 population), representing a reduction of about 86% (R While Eritrea has made significant progress towards malaria elimination, this progress should be maintained and further improved. Distribution, coverage and utilization of malaria control and elimination tools should be optimized and sustained to safeguard the gains made. Additionally, consistent annual performance evaluation of malaria indicators would ensure a continuous learning process from gains/threats of epidemics and resurgence in regions already earmarked for elimination.

Sections du résumé

BACKGROUND BACKGROUND
The present study focuses on both long- and short-term malaria transmission in Eritrea and investigates the risk factors. Annual aggregates of information on malaria cases, deaths, diagnostics and control interventions from 2001 to 2008 and monthly reported data from 2009 to 2017 were obtained from the National Malaria Control Programme. We used a generalized linear regression model to examine the associations among total malaria cases, death, insecticide-treated net coverage, indoor residual spraying and climatic parameters.
RESULTS RESULTS
Reduction in malaria mortality is demonstrated by the milestone margins of over 97% by the end of 2017. Malaria incidence likewise declined during the period (from 33 to 5 per 1000 population), representing a reduction of about 86% (R
CONCLUSIONS CONCLUSIONS
While Eritrea has made significant progress towards malaria elimination, this progress should be maintained and further improved. Distribution, coverage and utilization of malaria control and elimination tools should be optimized and sustained to safeguard the gains made. Additionally, consistent annual performance evaluation of malaria indicators would ensure a continuous learning process from gains/threats of epidemics and resurgence in regions already earmarked for elimination.

Identifiants

pubmed: 32164770
doi: 10.1186/s13071-020-3974-x
pii: 10.1186/s13071-020-3974-x
pmc: PMC7068948
doi:

Substances chimiques

Insecticides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

126

Références

Malar J. 2009 Aug 05;8:185
pubmed: 19653914
PLoS Med. 2014 May 13;11(5):e1001642
pubmed: 24824170
Malar J. 2010 Jun 10;9:156
pubmed: 20537127
Am J Trop Med Hyg. 2013 Apr;88(4):727-732
pubmed: 23419363
Sci Data. 2015 Dec 08;2:150066
pubmed: 26646728
Malar J. 2013 Jul 26;12:259
pubmed: 23890257
Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):61-8
pubmed: 18165476
Malar J. 2017 Feb 23;16(1):88
pubmed: 28231817
Malar J. 2006 Apr 24;5:33
pubmed: 16635265
Malar J. 2018 Oct 29;17(1):394
pubmed: 30373573
Malar J. 2013 Dec 20;12:458
pubmed: 24359262
Malar J. 2011 Dec 15;10:367
pubmed: 22171950
Am J Trop Med Hyg. 2010 Oct;83(4):861-7
pubmed: 20889880
Emerg Infect Dis. 2018 Mar;24(3):462-470
pubmed: 29460730
Lancet Glob Health. 2014 Feb;2(2):e98-105
pubmed: 25104666
J Med Entomol. 2013 Nov;50(6):1275-81
pubmed: 24843932
Malar J. 2017 Aug 1;16(1):308
pubmed: 28764792
J Med Entomol. 2003 Nov;40(6):921-9
pubmed: 14765671
Malar J. 2018 Nov 29;17(1):443
pubmed: 30497487
Malar J. 2013 Jan 08;12:10
pubmed: 23298401
PLoS Biol. 2016 Mar 02;14(3):e1002380
pubmed: 26934361
Malar J. 2017 Mar 6;16(1):105
pubmed: 28264689
Malar J. 2015 Dec 02;14:488
pubmed: 26630934
Malar J. 2014 Apr 23;13:153
pubmed: 24755108
Am J Trop Med Hyg. 2013 Sep;89(3):403-6
pubmed: 24006294
Geospat Health. 2015 Jun 03;10(1):330
pubmed: 26054519
Am J Trop Med Hyg. 2015 Jul;93(1):145-152
pubmed: 26013378
Trans R Soc Trop Med Hyg. 2013 Dec;107(12):745-52
pubmed: 24127210
Malar J. 2013 Dec 01;12:437
pubmed: 24289177

Auteurs

Selam Mihreteab (S)

National Malaria Control Programme, Ministry of Health, Asmara, Eritrea. smuqubay@gmail.com.

Jailos Lubinda (J)

School of Geography and Environmental Sciences, Ulster University, Coleraine, UK.

Bingxin Zhao (B)

Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Alfonso J Rodriguez-Morales (AJ)

Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia.
Medical School, Faculty of Health Sciences, UniFranz, Cochabamba, Bolivia.
Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Pereira, Risaralda, Colombia.

Ajlina Karamehic-Muratovic (A)

Department of Sociology and Anthropology, St Louis University, St. Louis, MO, USA.

Aman Goitom (A)

National Malaria Control Programme, Ministry of Health, Asmara, Eritrea.

Muhammad Yousaf Shad (MY)

Department of Statistics, Quaid-i-Azam University, Islamabad, Pakistan.

Ubydul Haque (U)

Department of Geography, University of Florida, Gainesville, FL, USA.
Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA.
Department of Biostatistics and Epidemiology, University of North Texas Health Science Center, Fort Worth, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH